Bukwang Pharm, Stem Cell Theme Rises 5.45% Up

On the 8th, the stem cell theme rose by 3.08% compared to the previous day, showing strength, while Bukwang Pharm, which is attracting attention as a related stock, surged by 5.45% compared to the previous day. Bukwang Pharm is known as a manufacturer of pharmaceuticals and quasi-drugs (such as toothpaste).

[Graph] Stem Cell Theme Major Stocks Price Change



According to provisional data compiled at 12:32, foreign investors sold 108,000 shares and institutions sold 61,000 shares of Bukwang Pharm, resulting in simultaneous large net selling by both foreign investors and institutions.

[Table] Foreign and Institutional Net Trading Volume (Unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Bukwang Pharm’s quant financial score is 15.13 points, ranking 11th within the stem cell theme, with higher stability and profitability scores compared to the average of other stocks related to stem cells. This indicates that Bukwang Pharm’s ability to respond to internal and external economic environment changes and its efficient profit generation capability are better than those of other stocks within the theme from a financial perspective.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of analysis by the robo algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.